Skip to main navigation
Skip to main content
Skip to footer

University Health Network

Search for:

Home
Theranostics Members
Publications
Clinical Trials
Contact Us
Skip to menu toggle button

Month: March 2021

Hello world!

Posted on: 12 March 2021 Last updated on: 12 March 2021 Written by: admtechna

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

Continue reading “Hello world!”…

Search for:

Recent Posts

Positron Emission Tomography/Computed Tomography (PET/CT) and Radioimmunotherapy of Head and Neck Cancer Patient Derived Xenografts in NRG Mice with Theranostic [64Cu]Cu-DOTA-Panitumumab F(ab’)2 and [177Lu]Lu-DOTA-Panitumumab F(ab’)2

Mol Pharm. 2025 Nov 3;22(11):6999-7009. doi: 10.1021/acs.molpharmaceut.5c01009. Epub 2025 Oct 21. ABSTRACT Head and neck squamous cell carcinoma (HNSCC) expresses epidermal growth factor receptors (EGFR) in 90% of cases. Here we studied PET/CT imaging of three clinically relevant HNSCC patient…

Continue reading “Positron Emission Tomography/Computed Tomography (PET/CT) and Radioimmunotherapy of Head and Neck Cancer Patient Derived Xenografts in NRG Mice with Theranostic [64Cu]Cu-DOTA-Panitumumab F(ab’)2 and [177Lu]Lu-DOTA-Panitumumab F(ab’)2”…

[18F]F-DCFPyL PET/MRI radiomics for intraprostatic prostate cancer detection and metastases prediction using whole-gland segmentation

Br J Radiol. 2025 Oct 1;98(1174):1606-1614. doi: 10.1093/bjr/tqaf014. ABSTRACT OBJECTIVES: To evaluate [18F]F-DCFPyL PET/MRI whole-gland-derived radiomics for detecting clinically significant (cs) prostate cancer (PCa) within the prostate gland and predicting extra-prostatic metastasis (N and M staging). METHODS: In this single-centre,…

Continue reading “[18F]F-DCFPyL PET/MRI radiomics for intraprostatic prostate cancer detection and metastases prediction using whole-gland segmentation”…

Prostate-specific antigen density does not predict metastatic disease on PSMA-PET in high-risk prostate cancer patients with negative conventional imaging

Can Urol Assoc J. 2025 Sep;19(9):E307-E311. doi: 10.5489/cuaj.9113. ABSTRACT INTRODUCTION: The ability of prostate-specific antigen density (PSAD) to predict metastatic disease on prostate-specific membrane antigen-positron emission tomography (PSMA-PET) at initial staging in high-risk prostate cancer (PCa) for men with negative…

Continue reading “Prostate-specific antigen density does not predict metastatic disease on PSMA-PET in high-risk prostate cancer patients with negative conventional imaging”…

Targeted Radionuclide Therapy Using a Lutetium-177 Labeled Human Anti-CD133 Antibody

Mol Imaging Biol. 2025 Aug;27(4):606-616. doi: 10.1007/s11307-025-02013-4. Epub 2025 May 22. ABSTRACT PURPOSE: Targeted radionuclide therapy against cancer stem cell-specific markers, such as CD133, constitutes a promising strategy to eliminate resilient cancer stem cells for improved outcomes in refractory tumors.…

Continue reading “Targeted Radionuclide Therapy Using a Lutetium-177 Labeled Human Anti-CD133 Antibody”…

PSMA PET-detected mesorectal nodal metastasis: treatment outcomes and clinical implications

World J Urol. 2025 Jun 3;43(1):352. doi: 10.1007/s00345-025-05733-y. ABSTRACT PURPOSE: To evaluate the clinical significance of PSMA-PET/CT-detected mesorectal lymph node metastases in biochemically recurrent prostate cancer patients. METHODS: This is a retrospective analysis of biochemically recurrent prostate cancer patients (post-radical…

Continue reading “PSMA PET-detected mesorectal nodal metastasis: treatment outcomes and clinical implications”…

Recent Comments

A WordPress Commenter on Hello world!

Archives

November 2025
October 2025
September 2025
June 2025
March 2025
November 2024
March 2024
December 2023
November 2023
September 2023
May 2023
February 2023
October 2022
August 2022
March 2021

Categories

Uncategorized

Meta

Log in
Entries feed
Comments feed
WordPress.org

Home
Theranostics Members
Publications
Clinical Trials
Contact Us

Search for:

© 2025 Theranostics | Using Icelander WordPress theme. | Privacy and Cookie Policy | Back to top ↑

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.